Concord Wealth Partners Ptc Therapeutics, Inc. Call Options Transaction History
Concord Wealth Partners
- $603 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PTCT
# of Institutions
232Shares Held
78.1MCall Options Held
144KPut Options Held
54.8K-
Vanguard Group Inc Valley Forge, PA9.13MShares$451 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$390 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$384 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$366 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$358 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.54B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...